(Q34333286)

1 August 2017

title

Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin (English)

1 reference

1 August 2017

1 reference

Yamane N

1

1 reference

1 August 2017

Jones RN

2

1 reference

1 August 2017

Frei R

3

1 reference

1 August 2017

Hoban DJ

4

1 reference

1 August 2017

Pignatari AC

5

1 reference

1 August 2017

Marco F

6

1 reference

1 August 2017

publication date

1 April 1994

1 reference

1 August 2017

published in

Journal of Chemotherapy

1 reference

1 August 2017

volume

6

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

83-91

1 reference

In vitro activity of DR-3355, an optically active ofloxacin

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

Synthesis and antibacterial activities of optically active ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

In vitro activity of S-ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

Inhibition of DNA gyrase by optically active ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

Increasing resistance of Staphylococcus aureus to ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

Quinolone resistance in clinical isolates of Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

Quinolone resistance. Susceptibility data from a 300-bed community hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1994.11741134

10.1080/1120009X.1994.11741134

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference